Eckert & Ziegler with a clear long-term strategy, stock in the German medtech segment
27.06.2026 - 09:23:22 | ad-hoc-news.de
By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-27, 09:22.
Eckert & Ziegler (DE0005659700) focuses on radioisotope-based components and services for medicine and industry, with the stock listed in the SDAX segment of Deutsche Börse and traded on Xetra in euros as a specialized medtech and nuclear technology player.
How the niche positioning works
The group was founded in 1997 in Berlin and has built its business around the preparation, distribution and handling of radioactive materials, supplying components for radiotherapy, nuclear medicine and industrial measurement technology.
In the medical segment Eckert & Ziegler provides sealed radioactive sources and equipment used in brachytherapy and nuclear imaging, supporting hospitals and oncology centers that use targeted radiation therapies for cancer treatment and diagnostic procedures.
Dual focus on medicine and industry
Alongside the medical activities the company operates an industrial segment that delivers radioactive sources for level gauges, thickness measurement and other process control systems used in sectors such as oil and gas, chemicals and manufacturing, embedding isotope technology deeply into industrial quality assurance workflows.
This dual focus on healthcare and industrial applications is reflected in the group structure with business units for Medical and Industrial divisions, generating revenue across both regulated hospital markets and long-term industrial supply contracts where reliability and compliance standards are central.
Background and data on the Eckert & Ziegler stock
Further company reports, price data and regulatory filings on Eckert & Ziegler are available via the dedicated topic page and the investor relations section.
The product behind the stock
At the core of the portfolio stands the medical segment, where Eckert & Ziegler supplies brachytherapy sources and related equipment that deliver targeted radiation directly to tumors, enabling hospitals to perform precise cancer treatments with standardized radioactive components.
Where the stock trades today
The Eckert & Ziegler shares (DE0005659700) trade on Xetra, with intraday prices and volumes quoted in euros on the Deutsche Börse systems for the SDAX-listed medtech stock.
Key data on the Eckert & Ziegler shares
- Company: Eckert & Ziegler AG
- ISIN: DE0005659700
- WKN: 565970
- Ticker: EUZ
- Trading venue: Xetra
- Price (as of 2026-06-26, 17:45): € (Xetra closing price not verifiable)
- Market cap: € (as of 2026-06-26, Xetra data not fully verifiable)
- Sector / industry: Health Care Equipment & Supplies / Medical Technology
- Index membership: SDAX
- Next earnings date: not officially scheduled
This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. All data and company information are based on publicly accessible sources and may change over time.
